Invitation to Roche investor science conference call from ASH 2013

Conference call on 9 December 2013

We kindly invited investors and analysts to participate in a conference call to discuss Roche’s hematology franchise, including new clinical data and results presented during the 2013 ASH annual meeting (The 55th Annual Meeting and Exposition of the American Society of Hematology, 7-10 December 2013, New Orleans, Louisana, USA):